Skip to main content

Table 1 Clinical features of TNBC and non-TNBC patients

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

  Non-TNBC TNBC P
Survival (months, median) 84.8 65.85 0.006#
Tumor size (units, median) 22 25 0.153#
Grade    <0.001*
 1 103 3  
 2 475 27
 3 462 165
Unknown 55 9
Stage    0.425
 0–2 863 155  
 3–4 88 22
Unknown 144 27
Lymph nodes    0.096
 No 606 100  
 Yes 489 104
Distal metastasis    0.578
 No 799 145  
 Yes 296 59
  1. TNBC triple negative breast cancer
  2. #Student’s t test
  3. *Chi-square test